Agios Pharmaceuticals (AGIO) Insider Trading & Ownership $53.78 -1.62 (-2.92%) (As of 04:24 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Agios Pharmaceuticals (NASDAQ:AGIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.93%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$2.11 M Get AGIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Agios Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AGIO Insider Buying and Selling by Quarter Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Agios Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/26/2024Cecilia JonesCFOSell2,542$49.03$124,634.26 8/8/2024Brian GoffCEOSell11,091$42.75$474,140.25 4/10/2024Jacqualyn A FouseDirectorSell7,791$27.55$214,642.05 3/5/2024Brian GoffCEOSell4,156$32.57$135,360.92 3/5/2024James William BurnsInsiderSell2,642$32.57$86,049.94 3/5/2024Kaye I Foster-CheekDirectorSell300$32.21$9,663.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/20/2024Theodore James Jr. WashburnInsiderSell504$26.63$13,421.52 2/14/2024Sarah GheuensInsiderSell642$25.14$16,139.88 1/24/2024Brian GoffCEOSell7,635$21.64$165,221.40 1/24/2024Cecilia JonesCFOSell1,886$21.64$40,813.04 1/24/2024Jacqualyn A FouseDirectorSell10,722$21.64$232,024.08 1/24/2024James William BurnsInsiderSell1,708$21.64$36,961.12 1/24/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$21.51$1,001 - $15,0001/9/2024Brian GoffCEOSell12,066$22.99$277,397.34 1/9/2024Jacqualyn A FouseDirectorSell8,391$22.99$192,909.09 1/9/2024James William BurnsInsiderSell1,163$22.99$26,737.37 1/5/2024Tsveta MilanovaInsiderSell2,902$22.32$64,772.64 (Data available from 1/1/2013 forward) AGIO Insider Trading Activity - Frequently Asked Questions Who is on Agios Pharmaceuticals's Insider Roster? The list of insiders at Agios Pharmaceuticals includes Brian Goff, Cecilia Jones, David P Schenkein, Jacqualyn A Fouse, James William Burns, Kaye I Foster-Cheek, Sarah Gheuens, Theodore James Jr. Washburn, and Tsveta Milanova. Learn more on insiders at AGIO. What percentage of Agios Pharmaceuticals stock is owned by insiders? 4.93% of Agios Pharmaceuticals stock is owned by insiders. Learn more on AGIO's insider holdings. Which Agios Pharmaceuticals insiders have been selling company stock? The following insiders have sold AGIO shares in the last 24 months: Brian Goff ($1,376,813.55), Cecilia Jones ($264,755.63), David P Schenkein ($3,002,694.55), Jacqualyn A Fouse ($943,537.70), James William Burns ($366,219.55), Kaye I Foster-Cheek ($658,663.00), Sarah Gheuens ($16,139.88), Theodore James Jr. Washburn ($138,443.95), and Tsveta Milanova ($64,772.64). How much insider selling is happening at Agios Pharmaceuticals? Insiders have sold a total of 256,436 Agios Pharmaceuticals shares in the last 24 months for a total of $6,832,040.45 sold. Which members of congress are trading Agios Pharmaceuticals? Josh Gottheimer (D-NJ) has bought shares of Agios Pharmaceuticals in the last year totaling $8,000. Agios Pharmaceuticals Key ExecutivesMr. Brian M. Goff M.B.A. (Age 55)CEO & Director Compensation: $1.23MMs. Cecilia Jones (Age 49)Chief Financial Officer Compensation: $403.36k1 recent tradesMr. James William Burns (Age 46)Corporate Secretary & Chief Legal Officer Compensation: $660.33kDr. Sarah Gheuens M.D. (Age 44)Ph.D., Chief Medical Officer and Head of Research & Development Compensation: $769.2kDr. Lewis Clayton Cantley Ph.D. (Age 75)Co-Founder & Member of Scientific Advisory Board Compensation: $50kDr. Tak Wah Mak D.Sc. (Age 78)FRSC, Ph.D., Co-Founder & Member of Scientific Advisory Board Dr. Craig B. Thompson M.D. (Age 71)Co-Founder & Chairman of Scientific Advisory Board Dr. Shin-San Su Ph.D. (Age 68)Co-Founder & Member of Scientific Advisory Board Mr. T. J. Washburn Jr. (Age 43)Principal Accounting Officer Dr. Clive Patience Ph.D. (Age 60)Chief Technical Operations Officer More Insider Trading Tools from MarketBeat Related Companies JAZZ Insider Transactions PCVX Insider Transactions SRPT Insider Transactions CTLT Insider Transactions RVMD Insider Transactions ITCI Insider Transactions ROIV Insider Transactions VKTX Insider Transactions ELAN Insider Transactions CYTK Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:AGIO) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agios Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agios Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AGIO Stock Alerts